Chan AT - Search Results

1

Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy.

Ma BB, Leungm SF, Hui EP, Mo F, Kwan WH, Zee B, Yuen J, Chan AT. Ma BB, et al. Among authors: chan at. Cancer. 2004 Aug 15;101(4):776-81. doi: 10.1002/cncr.20430. Cancer. 2004. PMID: 15305409 Free article.

2

Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients.

Whitney BM, Chan AT, Rickinson AB, Lee SP, Lin CK, Johnson PJ. Whitney BM, et al. Among authors: chan at. J Med Virol. 2002 Jul;67(3):359-63. doi: 10.1002/jmv.10073. J Med Virol. 2002. PMID: 12116028

3

Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, Gatter KC, Johnson PJ, Harris AL. Hui EP, et al. Among authors: chan at. Clin Cancer Res. 2002 Aug;8(8):2595-604. Clin Cancer Res. 2002. PMID: 12171890

4

Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer.

Yeo W, Mok TS, Tse KK, Kwan WH, Lam KC, Ho WM, Chiu SK, Chan AT, Leung TW, Mo FK, Johnson PJ. Yeo W, et al. Among authors: chan at. Anticancer Drugs. 2002 Jul;13(6):655-62. doi: 10.1097/00001813-200207000-00013. Anticancer Drugs. 2002. PMID: 12172512 Clinical Trial.

5

A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.

Mok TS, Wong H, Zee B, Yu KH, Leung TW, Lee TW, Yim A, Chan AT, Yeo W, Chak K, Johnson P. Mok TS, et al. Among authors: chan at. Cancer. 2002 Oct 1;95(7):1511-9. doi: 10.1002/cncr.10836. Cancer. 2002. PMID: 12237920 Free article. Clinical Trial.

6

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.

Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, Mo F, Lai M, Ho S, Huang DP, Johnson PJ. Chan AT, et al. Among authors: chan ly. J Natl Cancer Inst. 2002 Nov 6;94(21):1614-9. doi: 10.1093/jnci/94.21.1614. J Natl Cancer Inst. 2002. PMID: 12419787

7

Treatment strategy and clinical experience.

Teo PM, Chan AT. Teo PM, et al. Among authors: chan at. Semin Cancer Biol. 2002 Dec;12(6):497-504. doi: 10.1016/s1044579x02000925. Semin Cancer Biol. 2002. PMID: 12450735 Review.

8

Nasopharyngeal cancer.

Chan AT, Teo PM, Johnson PJ. Chan AT, et al. Cancer Treat Res. 2003;114:275-93. doi: 10.1007/0-306-48060-3_11. Cancer Treat Res. 2003. PMID: 12619546 Review. No abstract available.

9

Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients.

Chan KC, Zhang J, Chan AT, Lei KI, Leung SF, Chan LY, Chow KC, Lo YM. Chan KC, et al. Among authors: chan ly, chan at. Cancer Res. 2003 May 1;63(9):2028-32. Cancer Res. 2003. PMID: 12727814

10

Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.

Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ, Lo YM. Leung SF, et al. Among authors: chan ly, chan at. Cancer. 2003 Jul 15;98(2):288-91. doi: 10.1002/cncr.11496. Cancer. 2003. PMID: 12872347 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,258 results

Search Page

Filters